Catalyst Event
Amgen Inc (AMGN) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
6/3/2026, 12:00:00 AM
Presented new Phase 3 data for UPLIZNA at the EULAR 2026 Congress, showing a 0% flare rate over one year in patients with IgG4-Related Disease who continued treatment. Medium importance as positive clinical data supports market share, expected.
Korean Translation
EULAR 2026 학회에서 UPLIZNA의 새로운 3상 데이터를 발표함. 치료를 지속한 IgG4 관련 질환 환자에서 1년간 재발률 0%를 기록함. 긍정적인 임상 데이터는 시장 점유율 확대에 기여하므로 중간 중요도로 분류함, 예상됨.
Related Recent Events
Xiaomi Corporation (1810) · Earnings Release
Q2 2026 earnings release is scheduled. A low market impact is estimated as the specific financial results are not yet disclosed.
8/26/2026, 12:00:00 AM
Amazon.com Inc (AMZN) · Earnings Release
Amazon's Q2 2026 earnings release is expected on July 30, 2026. The company guided for net sales between $194.0 billion and $199.0 billion. Low importance is assigned as the market reaction has not yet occurred expected.
7/30/2026, 12:00:00 AM
Meta Platforms Inc (META) · Earnings Release
Meta Platforms is expected to release its Q2 2026 financial results after market close on July 29, 2026. Due to historical volatility during earnings for mega-cap tech stocks, a high price impact (>10%) is expected.
7/29/2026, 12:00:00 AM
Lam Research Corp (LRCX) · Earnings Release
Lam Research is expected to report its Q4 2026 earnings on July 29, 2026. Analysts forecast an EPS of approximately $1.65-$1.68. Market impact is estimated at Medium as earnings reports typically drive significant price volatility, scheduled.
7/29/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet Q2 2026 earnings release scheduled for July 22, 2026, with analysts forecasting EPS of approximately $2.85-$2.87 forecasted.
7/22/2026, 12:00:00 AM
International Business Machines Corp (IBM) · Earnings Release
IBM's Q2 2026 earnings announcement is scheduled for July 22, 2026, scheduled
7/22/2026, 12:00:00 AM